Theragenics Corporation TGX, a medical device company serving the
surgical products and prostate cancer treatment markets, announced today that
in view of the market activity in the Company's stock on Thursday, December
20, 2012, the New York Stock Exchange contacted the Company on December 24,
2012, in accordance with the Exchange's usual practice. The Company stated
that its policy is not to comment on market activity.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in